Health systems research for policy change: lessons from the implementation of rapid assessment protocols for diabetes in low- and middle-income settings by David Beran et al.
RESEARCH Open Access
Health systems research for policy change:
lessons from the implementation of rapid
assessment protocols for diabetes in low-
and middle-income settings
David Beran1*, J. Jaime Miranda2, Maria Kathia Cardenas2 and Maryam Bigdeli3
Abstract
Background: As many challenges exist for access to diabetes care in developing countries, the International Insulin
Foundation developed a Rapid Assessment tool and implemented this approach to identify barriers to care and
propose concrete recommendations for decision makers. The objective of this paper is to identify the factors that
contributed to informing and influencing policymakers with regards to this work.
Methods: A documentary review comprised Stage 1. Stage 2 used an online questionnaire to gain insight from
users of the Rapid Assessment results. Based on Stages 1 and 2, Stage 3 comprised in-depth interviews with a total
of nine individuals (one individual each from the six participating countries; two individuals from the World Health
Organization; one “Global Diabetes Advocate”). Interviews were analyzed based on a list of themes developed from
Stage 2.
Results: Stage 1 led to the identification of various types of documents referring to the results. The online questionnaire
had a response rate of 33%. Respondents directly involved in the assessment had a “Good” or “Very Good” appreciation
of most aspects and scored these higher than those not directly involved. From the interviews, formalized
methods and close collaboration between the international team and local partners were strengths. Trust and a
relationship with local partners were also seen as assets. All stakeholders valued the results and the credibility of
the data generated. Local partners felt that more could have been done for dissemination.
Conclusion: This study shows the importance of specific results from the different assessments. In addressing
complex issues having external experts involved was seen as an advantage. The uptake of results was due to the
credibility of the research which was influenced by a mix of the people involved, past assessments, trusted local
partners, and the use of the results by knowledge brokers, such as the World Health Organization. Through these
brokers, others gained ownership of the data. The methods used and the fact that this data was grounded in a
local context also reinforced its value. Despite limitations, this study offers a unique perspective where a similar
research approach was taken in six countries.
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Background
Diabetes, which led to 1.3 million deaths in 2010 [1], is
one of the four conditions prioritized by the World
Health Organization (WHO) in its Global Action Plan
for the prevention and control of non-communicable
diseases (NCD) 2013–2020 [2]. Access to diabetes care
in developing countries is described as being problem-
atic with most of the factors documented relating to ac-
cess to medicines and especially insulin [3-5]. Other
issues related to the health system, healthcare worker train-
ing, and access to diagnostic facilities and syringes, are
known to also have a negative impact in availability and
provision of diabetes care, but are not widely described.
To address this problem, the International Insulin
Foundation (IIF) developed the Rapid Assessment Protocol
for Insulin Access (RAPIA) [6]. The RAPIA is structured as
a multi-level assessment tool for health systems research. It
studies the different elements that influence access that
people with diabetes have to care in a given country. The
data collection process provides a country-specific
situation analysis regarding diabetes care including ac-
cess to medicines. This approach also highlights the
strengths and weaknesses of the health system in pro-
posing concrete actions [7-9]. To date, the RAPIA
has been implemented by the IIF in six countries, span-
ning four WHO Regions: Kyrgyzstan, Mali, Mozambique,
Zambia, Nicaragua, and Vietnam [10-15]. Table 1 de-
scribes the main elements of the RAPIA.
In these six countries, the RAPIAs were the first NCD-
or diabetes-specific research carried out. Besides highlight-
ing the barriers to care, the RAPIA helped estimate life ex-
pectancy, the burden of disease, and the cost to the health
system. From a policy perspective, the RAPIA resulted
with diabetes being included as part of the existing cardio-
vascular disease program in Kyrgyzstan, thereby expand-
ing the area of NCDs within the country’s national health
program [16]. In Mozambique, the RAPIA recommenda-
tions were incorporated into an overall NCD Strategy [17]
rather than being diabetes specific.
Gilson [18] defines health policies as “actions through
which efforts are made to strengthen health systems in
order to promote population health”, but as stated by the
WHO, very little is known about how to facilitate the
use of research in developing countries [19]. Hanney et al.
[20] state that a gap in the research in the area of using
health systems research in policy is linked to the under-
standing of how research is used, and as discussed by
Hyder et al. [21], this is linked to the interface between re-
search and policy. Therefore, the objective of this paper is
to analyse the RAPIA implementation and the factors that
contributed to informing and influencing policymakers in
Kyrgyzstan, Mali, Mozambique, Nicaragua, Vietnam, and
Zambia.
Methods
The first stage included a documentary review to iden-
tify peer-reviewed publications, reports, and other pub-
lished materials, which included the results of the
RAPIA. For peer-reviewed publications Web of Know-
ledge and PubMed were used to assess the number of ci-
tations these articles had. In addition, for all open access
articles the number of accesses was found.
As the objectives of the IIF’s research was not only to in-
form academic audiences, but were rather targeted at pol-
icymakers, a general search strategy using Google was
developed. This search strategy used the search terms
shown in Table 2, restricted to the years 2003 until 1 May
2013. Each term was combined using the term connector
“AND”, for example “International Insulin Foundation”
AND “NCD Alliance”. In addition, the title of the
RAPIA report in French (Mali), Portuguese (Mozambique),
Spanish (Nicaragua), Russian (Kyrgyzstan), and Vietnamese
(Vietnam) was entered into a Google search engine. The
aim of this search was to identify documents that had used
or referenced material produced by the IIF using the
RAPIA tool.
Stage 2 used the results from the above search to de-
velop a list of individuals who had used or referred to re-
sults from the different RAPIAs. These included authors
of peer reviewed publications, reports, and news items.
In addition, the IIF kept a list of individuals who had
contacted it about the RAPIA in reference to the tool or
Table 1 Key components of the RAPIA [6]
- Data collection tools tailored to different levels of the
health system and key informants
○ Purposive and convenience sampling
- Multiple methods of data collection
- Multiple data sources
○ Interviews
▪ Ministry of Health, health professionals, health facilities,
traditional healers, individuals with diabetes, etc.
○ Site visits
▪ Three areas of the country
• Capital City
• Urban area
• Predominantly rural area
○ Document reviews
○ Use of existing statistics
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its results and these people were also added to this list.
All these people were sent an introductory e-mail de-
scribing the study and a link to a web-based question-
naire, which included a 3-week response period. After 2
weeks, a reminder was sent. The aim of the question-
naire was to assess the perceptions of these individuals
with regards to which elements of the RAPIA helped im-
pact on policy. This survey was conducted between
March 26 and April 12, 2013. The questionnaire had a
total of 27 questions with a mix of Likert scales (Very
Poor to Very Good and Strongly Disagree to Strongly
Agree) giving scores from 0–5 and areas where individ-
uals could add their comments. The first questions tried
to gain some background information on the respond-
ent. People then had to answer if they had knowledge of
the IIF or not. Those with knowledge of the IIF were
asked if they were directly involved in the implementa-
tion of a specific RAPIA. Those who were not directly
involved in the RAPIA were asked how they came to
know about the IIF’s work. Those who stated that they
were unaware of the IIF’s work were asked if they knew
about the work of individuals involved with the IIF. The
questionnaire then asked questions looking at aspects of
quality related to (1) methods used in the RAPIA; (2)
quality of the research team; (3) credibility of the re-
search team; (4) involvement of local partners during the
research process; (5) quality of the results from the
RAPIA; (6) quality of the recommendations from the
RAPIA; (7) quality of the dissemination of the RAPIA
results; and (8) priority setting exercises. The answers
from these questions helped develop the items for dis-
cussion used in the next stage.
A more in-depth look at what some key stakeholders
thought of the RAPIA and IIF’s work was carried out
during Stage 3 using the information collected from
Stages 1 and 2. One of the main partners in each of the
six countries where the RAPIA was carried out, except
in Zambia where two were included, was contacted and
asked if they were willing to participate in an interview.
In addition, two WHO officers, one from Headquarters
and the other from a country office, and a Global Dia-
betes Advocate active in the area of access to insulin
were also interviewed. These individuals were selected
due to their close links with the implementation of the
RAPIA in each country or knowledge of the work done
by the IIF from a more global perspective. Interviews
were carried out by DB on the phone or Skype, in May
2013, and lasted on average of 46 minutes. Detailed
notes were taken during each interview. Thematic ana-
lysis was carried out using the headings from a discus-
sion guide. Using answers from the online questionnaire
a discussion guide was developed focusing on:
– RAPIA Methods
– Research team and collaboration
– Results from the RAPIA implementations
– Dissemination of RAPIA results
– Recommendations from RAPIA reports
This research proposal was submitted to the Ethics
Board at the Geneva University Hospitals.
Results
Documentary review
Table 3 presents the citations and accesses (where
publications enabled authors to see how many times
their articles have been viewed online) of the different
peer reviewed publications published as a result of
the RAPIA. The results from the Google search found
that organizations such as the Hanoi School of Public
Health, Health Action International, International
Diabetes Federation, NCD Alliance [22], NCD Child
[23], Novo Nordisk [24,25] (leading insulin manufac-
turer), RAND Health, the World Bank [26], and
WHO at Headquarter, Regional, and National levels
(summarized in Table 4), either referenced the publi-
cations detailed in Table 3 or one of the RAPIA
country reports. The WHO Essential Medicines and
Health Products website also includes a list of publi-
cations comprising the results from the different
RAPIA implementations [27].
The Google search also identified news items from dif-
ferent mass media around the world, such as the BBC
[28], Guardian [29], Financial Times [30], Asia Life [31],
and the British Medical Journal [32], which referenced
the RAPIA results or included interviews with people
Table 2 Search terms for Google search
Search terms NCD Alliance IDF WHO UN HLM Mozambique Zambia Mali Nicaragua Vietnam Kyrgyzstan
International Insulin Foundation




IDF - International Diabetes Federation.
WHO - World Health Organization.
UN HLM - United Nations High Level Meeting on Noncommunicable diseases.
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involved with the IIF discussing findings from the
RAPIAs and their wider implications. During this over-
all Google search it was found that 15 textbooks also
referenced IIF publications.
Online questionnaire
The questionnaire was sent to a total of 167 people,
with individuals in each country where the RAPIA
had been implemented representing 66 possible re-
spondents and 85 individuals seen as international
partners; international partners may have collaborated
with the IIF or cited its work, but were not directly
involved in a specific assessment. Figure 1 details the
response to the overall questionnaire. The overall
response rate was 33% (n = 55). Only nine out of the
55 respondents stated they were directly involved in
the implementation of the RAPIA. Of these, two were
from Kyrgyzstan, one from Mali, three from Mozambique,
zero from Nicaragua, two from Vietnam, and one
from Zambia. Responders who stated that they were
not directly involved in the implementation of an
in-country assessment (n = 36), had heard about the
IIF through peer reviewed publications (53%), seen a
presentation about this work (53%), read about this





Non-communicable diseases in Mozambique: risk factors, burden,




Improving access to insulin: what can be done? Diabetes Management NR 2 NR
The insulin dilemma in resource-limited countries. A way forward? Diabetologia 8 10 NR
The Diabetes UK Mozambique Twinning Programme. Results of
improvements in diabetes care in Mozambique: a reassessment
6 years later using the Rapid Assessment Protocol for Insulin Access
Diabetic Medicine 4 6 NR
Looking beyond the issue of access to insulin: What is needed for




Twinning for better diabetes care: a model for improving healthcare




Access to medicines versus access to treatment: the case of type 1
diabetes
Bulletin of the World
Health Organization
5 14 NR
Le diabète: un nouvel enjeu de santé publique pour les pays en voie




Diabetes Care in sub-Saharan Africa Lancet 44 99 NR
Assessing health systems for type 1 diabetes in sub-Saharan Africa:




Access to care for patients with insulin-requiring diabetes in developing
countries: case studies of Mozambique and Zambia.
Diabetes Care 24 60 NR
Prognosis of diabetes in the developing world Lancet 2 4 NR
NR, Not referenced.
Table 4 Use of International Insulin Foundation materials by the World Health Organization
Level of WHO Title of document
Headquarters Prioritized Research Agenda for Prevention and Control of Noncommunicable Diseases [44]
Headquarters Essential Medicines for Noncommunicable Diseases [45]
Headquarters Equity, social determinants and public health programmes [46]
Headquarters Noncommunicable Diseases, Poverty and the Development Agenda [47]
WHO Regional Office for Africa WHO African Region Ministerial Consultation on Noncommunicable Diseases background document [48]
WHO South-East Asia Regional Office Technical report on Social disparities in health in the Maldives [49]
WHO Country Office Kyrgyzstan Report included on website [50]
WHO Country Office Vietnam Medicines Prices: Policy options for Vietnam [51]
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work but not in a peer reviewed publication (33%), or
in an different way (19%), including mainly meetings
and being informed about this work through col-
leagues as well as the IIF’s website. For those who
stated they were unaware of the work of the IIF, they
were asked if they knew about the work of the
Trustees and Advisor to the Board of the IIF regard-
ing access to insulin. Overall, 80% of these individuals
responded positively and 86% had heard about this
work from a presentation given by either of these
individuals.
The answers show that those who stated that they
were directly involved in the RAPIA in each country had
a “Good” (score of 4) or “Very Good” (score of 5) appre-
ciation of most aspects of the RAPIA. Overall, those
stating that they were directly involved scored each of
these elements higher than those stating they were not
directly involved. For those stating that they were not in-
volved, the quality of the research team and results was
scored lower than by those stating that they were dir-
ectly involved. Both groups viewed dissemination as the
weakest element (Table 5). In looking at some of the
comments left with regards to dissemination, one re-
spondent stated, “The work of the IIF has an evidence-
informed body of work that could be better leveraged to
influence policy”. Another respondent highlighted this
issue for dissemination of results at an international level
saying that the “IIF has been preaching to the converts,
i.e. the diabetes community”.
Interviews
From the 10 people contacted, nine were inter-
viewed. The analysis of the themes yielded the fol-
lowing insight.
RAPIA methods
The Global Diabetes Advocate and Vietnamese partner
stated that a strength of the RAPIA was that it provided
“a formalized approach” to documenting the situation
with regards to diabetes care and access to insulin in
low- and middle-income countries. The Vietnamese
partner added that other strengths were that the RAPIA
used methods, which were “pre-packaged” and had
already been used elsewhere. Partners from Kyrgyzstan,
Nicaragua, and Zambia, as well as the WHO Country
Officer, highlighted the RAPIA’s comprehensive struc-
ture studying all levels of the health system. The Kyrgyz
and Nicaraguan partners added that another of the
RAPIA’s strengths was its ability to adapt to the specific
context and health system in different countries.
The WHO Country Officer, in describing the methods
and their use, stated that the “methods are quite good as
it not only provides availability and affordability infor-
mation, but also health system barriers to diabetes care”.
Figure 1 Details of responses to online questionnaire
Table 5 Rating of different elements of Rapid Assessment Protocol for Insulin Access (RAPIA) process by respondents
directly and not directly involved in local assessments
Element of the RAPIA Directly involved Not directly involved
Methods used in the RAPIA 4.9 4.8
Quality of the research team 4.9 4.6
Credibility of the research team 4.9 4.7
Involvement of local partners during the research process 4.8 4.7
Quality of the results from the RAPIA 4.9 4.6
Quality of the recommendations from the RAPIA 4.8 4.7
Quality of the dissemination of the RAPIA 4.4 4.2
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This person went on to add that “prices and availability
surveys do not include context – RAPIA does as it pro-
vides information about: the different levels of the health
system; human resources; financial aspects and overall
context. It gives an overview of diabetes treatment as a
whole and not only medicines”.
An interesting point raised by the Kyrgyz partner was
that, as the methods require site visits and interviews at
different levels of the health system, this created “noise
about the study” and therefore got people interested in
the study early on.
Research team and collaboration
The partners in Kyrgyzstan, Mali, Mozambique, and
Vietnam mentioned the close collaboration between the
IIF and local partners as a strength of the research team.
The WHO Country Officer stated that the IIF was able
to build trust and a relationship with local partners and
address difficult issues around access to medicines and
care. The partner in Vietnam stated that “looking at ac-
cess to medicines and insulin is complex” and that cap-
acity to do this in low- and middle-income countries is
limited and that this is what the IIF brought. The contri-
bution by the local partner was an understanding of the
local situation and the right people to help. In Mali, the
partner also added that having an external person (DB)
allowed for the RAPIA to be “critical”, which may not
have been possible for an internal team on its own.
Results from the RAPIA implementations
All individuals interviewed highlighted that the RAPIA
was the first study of its kind to be carried out in these
different countries and all stakeholders involved valued
it. The WHO Country Officer stated that the issue of af-
fordability and access to medicines is controversial, but
important, and the scientific approach and involvement
of local partners in the data collection helped with the
ownership of the data and the use of this data locally. In
Vietnam, the partner stated that the results and report
were read by many and this was useful to different
people and not only policymakers as the wealth of re-
sults was useful for everyone.
Interviewees from Kyrgyzstan, Mozambique, and
Vietnam stated that the RAPIA results had an impact on
policy. In Mozambique “data collected by the RAPIA
showed that diabetes was a public health problem in
Mozambique and was used in the best possible way as
this was included in the NCD Strategic Plan, National
Health Policy, Government Plans and project proposals”.
The results from the RAPIA were included in a strategy
on diabetes in Kyrgyzstan and were seen as “very import-
ant for policy development” in Vietnam.
The WHO Country Officer, in describing why the
RAPIA results had an impact on policy development,
stated that this was due to the specific data collected on
the affordability of medicines, the high financial burden
on individuals, and especially that “prices for Essential
Medicines were high and unaffordable”. This aspect was
also highlighted by the partner in Nicaragua in terms of
medicines, but also globally for the issue of diabetes and
provided “evidence of what was there and what was hap-
pening”. The partner in Zambia also stated that it
“showed people involved [in diabetes] the challenges”
adding that this was specifically with regards to insulin
access and healthcare worker training.
One piece of information highlighted as having a large
impact by the partners in Mozambique and Vietnam, as
well as the Global Diabetes Advocate, was the calculations
the IIF made using the RAPIA on life expectancy for
people with Type 1 diabetes. The Global Diabetes Advo-
cate mentioned that this data was useful despite its serious
assumptions. They also highlighted that the RAPIA was
able to quantify issues that people knew about, but did
not have data on, for example, travel costs.
Another useful aspect of the results from the RAPIA
that was discussed by the WHO Country Officer was
that statistics on affordability exist, but that the RAPIA
gave family stories and a personal perspective to the
issue. They stated that these small factual stories made
the difference and “for policymakers 5–10% are inter-
ested in the science, but practical examples have much
more impact”.
In terms of credibility, there was the credibility of the
data generated by the IIF through the RAPIAs, but also
the credibility of the IIF as an organization. From the
perspective of the Global Diabetes Advocate, some of
the IIF’s positions on access to insulin were detrimental.
They stated that there was the need to sometimes set
aside “personal views versus larger picture” and the need
to avoid being dogmatic. However, these same positions
were what gave the partner in Vietnam the confidence
and interest in working with the IIF as they viewed the
IIF as an organization with “integrity and objectivity”.
Dissemination of RAPIA results
In looking at the dissemination, the partners from
Nicaragua and Mozambique felt that more “noise” could
have been made during the dissemination and a wider
spectrum of people included in the formal dissemination
of the report. The partner in Mali echoed this and said
the dissemination went very well, but more could always
be done. The partner in Vietnam added that it was also
felt that more people should have been included in the
dissemination as well as more time with beneficiaries,
i.e. people with diabetes to explain the results to them.
The Kyrgyz partner was extremely positive about the
dissemination in terms of the roundtable and the discus-
sion with policymakers. They mentioned that the initial
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reaction was not a positive one as local stakeholders felt
that the results were negative, but after the dissemin-
ation and discussion they really appreciated the report
and found the results very important. Another positive
comment from Kyrgyzstan was the holding of a closed
door meeting with the Ministry of Health before the
wider dissemination to address some issues and present
initial findings; it was felt that this added importance to
the results. Another factor that added importance to the
results was the presence of international experts at the
workshop where the RAPIA results were presented.
In the country where the WHO Country representa-
tive worked, the dissemination continued beyond the
formal presentation of the RAPIA results with the WHO
and other local partners taking ownership of the results
and using them in policy briefs and a presentation to the
national assembly in 2010. This person highlighted that
the formal dissemination helps in different stakeholders
coming together, but that “one-off dissemination is not
enough and this needs to be sustained”. In Mozambique,
this was seen as possible as the local partner was viewed
as a “champion” for NCDs and was able to use the data
to move their agenda forward; for example, some of the
data collected on poor distribution of insulin to regional
medical stores and low life expectancy of children with
diabetes. From the perspective of the WHO Officer at
Headquarters “together with Health Action International
the data from the IIF’s work is widely quoted and used in
looking at the issue of access to medicines for NCDs”.
The interviewees mentioned the IIF’s reports and publi-
cations in terms of dissemination of the results from the
different RAPIAs.
Recommendations from RAPIA reports
All partners stated that the recommendations proposed
by the RAPIA were extremely useful to in-country part-
ners. In Mozambique, “the recommendations provided in
the report of the assessment were simple and clear for
the Ministry of Health and they felt that they could im-
plement these recommendations”. In Nicaragua, “author-
ities responded positively to the recommendations”. The
partner in Vietnam stated that the recommendations
were “clear, useful, helpful, offer new light” on a variety
of inter-related issues regarding access to diabetes care.
In Kyrgyzstan, the recommendations served as a basis
for a strategy and program on diabetes. The WHO Offi-
cer at Headquarters asserted that “recommendations
adapted to the local context were a strength of this
process and allowed countries to make small, but signifi-
cant changes as to how they approached the issue of
diabetes”.
From a global perspective, the Global Diabetes Advo-
cate stated that the recommendations were “straight for-
ward and useful on a global level”. They added, though,
that the approach and views of the IIF sometimes ham-
pered the implementation of these.
Limitations
Methods for policy analysis and impact are increasingly
diverse [33]. Some use qualitative methods [34], docu-
ment reviews, and key informant interviews using an
interview guide [35], and others suggest bibliometric
analyses and how this data is included in other studies,
through documentary analysis and interviews [20]. The
approach taken here was to combine methods several
methods [19,20,34,35]. This research is really a snapshot
and it was often hard to disassociate what was impacted
by the RAPIA and how this was done. For the document
review, any limits in the search strategy and also docu-
ments published but unavailable freely on the Internet,
may mean that key impacts of the RAPIA were missed.
Overall, the low number of local respondents and low
rate of response from local partners to the online ques-
tionnaire, the main people involved in the RAPIA
process, limits the assessment of what truly happened
on the ground. Further, since many of the individuals in-
cluded had referenced the RAPIA or contacted the IIF
about its work, this clearly represents a source of bias.
In reviewing response rates for online questionnaires
from different studies, Dobrow et al. [36] found that they
ranged from a minimum of 27.3% to maximum of 39.8%
with a best estimate of 32.8%. Nulty [37], in a similar re-
view, found that online surveys achieved response rates
that were much lower than paper-based ones (on aver-
age, 33% compared with 56%). Therefore, the response
rate to this survey can be seen as relatively high.
The selection of interviewees for the in-depth inter-
views was performed using a convenience sample and as
the respondents knew the main researcher and had
worked with him this may have led to some bias. As
stated by Woelk et al. [35], in looking at translating re-
search into policy, this type of research is influenced by
the respondents, their role at the time of the study, and
their relationship to the researcher. Many of the partners
were self-selecting at the time of the study due to their
interest in the topic, this already establishes a pre-
existing bias. In addition, as some of the collaborations
were 10 years ago, the issue of recall bias may also play
a role. Further, in some countries there may have been
ongoing collaborations whereas, in others, the RAPIA
was the only joint project, which may have also influ-
enced responses.
Conclusion
Overall, as described in this project by the interviewees
and by Panisset et al. [38], the RAPIA helped to map the
context, identify barriers and their determinants, and
propose practical solutions and recommendations.
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Specific results from the RAPIAs were viewed as import-
ant, such as the calculations of life expectancies and also
highlighting the issue of access to diabetes care and in-
sulin from a personal view. Getting the perspective from
the Officer from the WHO Headquarters helps in asses-
sing the impact of the RAPIA and IIF’s work. This per-
son stated that “The material produced from the
different implementations of the RAPIA have been in-
cluded in various WHO documents and helped develop
Regional and Global Action plans on the issue of access
to medicines for NCDs”. This was possible according to
this individual as the research and advocacy from the IIF
informed WHO policy with regards to the issue of ac-
cess to insulin and this material was also included in
documents produced by the International Diabetes Fed-
eration and NCD Alliance in the run-up to the UN High
Level Meeting in September 2011. This was also true
from the perspective of the WHO Country Officer re-
garding the impact of the RAPIA and its results from a
national and regional level with the government issuing
a statement on access to medicines for NCDs. The Offi-
cer from the WHO Headquarters added “as the IIF was
able to substantively document the issue of the lack of ac-
cess to medicines for NCDs, it was able to influence
WHO and other stakeholders on this issue, including dis-
cussions within WHO on the issue of access to insulin
and NCD medicines; the UN High Level Meeting on
NCDs; Global Action Plan on NCDs and the inclusion of
the 80% target on availability”.
One aspect highlighted in the online questionnaire
and interviews was the credibility of the research. This
element is viewed as important by Stone et al. [33] and
they link this to ‘peer review’, and that the individuals
are linked to recognized institutions and are viewed as
experts. For the RAPIA, this credibility was based on a
mix of the people involved with the IIF, the past results
of other RAPIA assessments, linking with trusted local
partners, and the use of the RAPIA results by knowledge
brokers such as the WHO and NCD Alliance. This not
only gave credibility to the results as these were used by
leading organizations, but also furthered the dissemin-
ation of results. Davis and Howden-Chapman [39] dis-
cuss the issue of transmitting the results of research
versus these results being received and then actively
used. This highlights the issue of ownership of data and
how, in one country , the WHO and other local partners
took ownership of the results using it in policy briefs
and a presentation to the national assembly in 2010.
This was possible because of the methods used as well
as the fact that this research was viewed as the first of
its kind in terms of the issue studied and the number of
countries where this research had taken place. One as-
pect that should not be neglected is the timing of this
work from 2003 to 2010, a period during which NCDs
and diabetes were gaining prominence on the global
health agenda. Also of importance is the fact that the re-
search was “grounded” in data that was relevant to the
given country [19] and that this highlighted local prob-
lems enabling the development of local solutions
(grounded in the local reality) [40]. This was facilitated
by close collaboration between local partners and the
IIF. Woelk et al. [35] mention the issues of trust, man-
aging the political environment, and using champions at
different levels to influence change. This was also dis-
cussed in having external versus internal people raise cer-
tain issues, but that the overall process was seen as a
collaboration.
Despite the limitations of this work, the experience of
the IIF using the RAPIA offers a unique perspective in
which a similar research approach has been taken in six
countries, allowing for insight into how health systems re-
search can impact policy (Table 6). As with many studies
assessing policy, this research only provides a snapshot
due its methodological approach. The implementation of
these recommendations would have been a good way to
assess the impact of the RAPIA on policy. This was per-
formed in Mozambique with a reassessment of the RAPIA
showing some progress in terms of initial recommenda-
tions regarding access to insulin, healthcare worker train-
ing, access to diagnostics, and the increased role of the
diabetes association, as well as the first national NCD
strategy in sub-Saharan Africa [41]. Translation of re-
search into policy is a complex process to understand;
therefore, lessons from this study will be integrated into
the WHO Manual How to Investigate Access to Chronic
NCDs Care in Low- and Middle-income Countries [42],
which is based on the RAPIA, to include the link between
the research findings and policymakers from the begin-
ning of such assessments. This approach has been piloted
in Peru [43] to allow for a more transversal assessment to
Table 6 Key lessons from the implementation of the Rapid
Assessment Protocol for Insulin Access in six low- and
middle-income countries
Lessons learnt
– Need for a formalized approach and robust methodology
– Credibility of research team
– Strong local partners
– Research fills a clear gap in knowledge
– Having context-specific results able to yield explicit
recommendations
– Need for a strong and comprehensive dissemination strategy
involving a variety of local partners and strong local champions
– Availability of results in peer reviewed publications, websites, and
presentations
– Importance of knowledge brokers, such as the WHO, and the need
to influence these brokers in order to help inform policies
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understand the link between this type of assessment and
influence on policymakers at each step of the process. For
the Global Action Plan, the WHO Officer at Headquarters
felt that this new manual developed based on the initial
RAPIA by the WHO and IIF “will be an essential tool in
the Monitoring and Evaluation of this target” and by un-
derstanding links with policy, hopefully this will not only
enable data to be collected, but for its use to be effective
to inform and influence policymakers.
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